Cargando…

Editorial: The Cell Types of Fibrosis

Detalles Bibliográficos
Autor principal:	Murray, Lynne A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722104/ https://www.ncbi.nlm.nih.gov/pubmed/26834635 http://dx.doi.org/10.3389/fphar.2015.00311

Ejemplares similares

Living with Fibrosis: From Diagnosis to Future Hope
por: Sleeman, Matthew A., et al.
Publicado: (2015)

Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Editorial: Premature Aging and Senescence in Renal Fibrosis
por: Samarakoon, Rohan, et al.
Publicado: (2021)

Editorial: Fibrosis: etiology, pathophysiology, measurements, and therapy
por: Liu, Yanping, et al.
Publicado: (2023)

Editorial: Applications of medicine in treating pulmonary fibrosis
por: Li, Wenjun, et al.
Publicado: (2023)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
por: Ruaro, Barbara, et al.
Publicado: (2022)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: New Insights Into Renal Fibrosis and Therapeutic Effects of Natural Products
por: Xu, Ying, et al.
Publicado: (2022)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies
por: Xu, Jun, et al.
Publicado: (2014)

Editorial: Translational Approaches for Targeting Cardiovascular Complications of Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2021)

Mesothelial cells in tissue repair and fibrosis
por: Mutsaers, Steven E., et al.
Publicado: (2015)

Cell-Based Therapies for Tissue Fibrosis
por: Lim, Rebecca, et al.
Publicado: (2017)

Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
por: Totani, Licia, et al.
Publicado: (2021)

The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis
por: Alhomrani, Majid, et al.
Publicado: (2017)

Editorial: New opportunities in drug design for the management and treatment of type 2 diabetes
por: Rasouli, Hassan, et al.
Publicado: (2023)

Editorial: Receptor Biology and Cell Signaling in Diabetes
por: Srivastava, Swayam Prakash, et al.
Publicado: (2022)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies
por: Vaz, Ana Rita, et al.
Publicado: (2022)

Editorial: Liver diseases and programmed cell death
por: Cao, Peng, et al.
Publicado: (2023)

Editorial: Purinergic Pharmacology
por: Ciruela, Francisco, et al.
Publicado: (2019)

Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
por: Allan, Katelin M., et al.
Publicado: (2021)

Editorial: Mechanisms of Traditional Medicinal Plants Used to Control Type 2 Diabetes or Metabolic Syndrome
por: Eddouks, Mohamed, et al.
Publicado: (2021)

Editorial: Role of Blood Cells in Inflammatory and Vascular Disorders
por: Brancaleone, Vincenzo, et al.
Publicado: (2020)

Editorial: Stem Cells as Targeted Drug Delivery Vehicles
por: Kusuma, Gina D., et al.
Publicado: (2020)

Editorial: Different cell death modes in cancer treatment
por: Bai, Zhaoshi, et al.
Publicado: (2023)

Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Drugs and Targets in Fibrosis
por: Li, Xiaoyi, et al.
Publicado: (2017)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Editorial: Serotonin and Memory
por: Meneses, Alfredo, et al.
Publicado: (2016)

Editorial: Sigma Receptors
por: Aydar, Ebru, et al.
Publicado: (2020)

Editorial: Eicosanoids in Cancer
por: Markosyan, Nune, et al.
Publicado: (2021)

Editorial: Angiogenesis and Nutraceuticals
por: Trabalzini, Lorenza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_avgaktbt8k63tf74u9d4gjnmck